CLINICAL TRIAL / NCT03585660

Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy

  • Interventional
  • Recruiting
  • NCT03585660

MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).